Titlebook: Colorectal Cancer; Evidence-based Chemo Maurie Markman,Leonard B. Saltz Book 2007 Humana Press 2007 angiogenesis.cancer.cancer treatment.co

刪減

Expertensysteme und Simulationsmodelle,is influenced by many factors, such as the nature of the first-line therapy, the potential toxicity of one regimen vs another, and the overall goal of treatment for the patient. In this chapter, we focus our discussion on the therapeutic strategies that can be used in the treatment of colorectal cancer after the failure of first-line therapy.

ineffectual

發(fā)現(xiàn)

易受騙

Chemoprevention of Colorectal Cancer,ruption of β-catenin-mediated signaling in colon epithelial cells. The 1,2-dimethylhydrazine (DMH)/azoxymethane (AOM) model of chemically induced colorectal cancer (CRC) and the murine multiple intestinal neoplasia (Min) model have provided useful information about the efficacy of available chemopre

BOLUS

Heresy

Cytotoxic Chemotherapy for Metastatic Colorectal Cancer,de the topoisomerase I inhibitor irinotecan, the third-generation platinum analog oxaliplatin, and the oral fluoropyrimidine capecitabine, in addition to the mainstay, fluorouracil. The use of these agents is discussed in this chapter.